SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-17-000048
Filing Date
2017-01-09
Accepted
2017-01-09 07:00:12
Documents
1
Period of Report
2017-01-09

Document Format Files

Seq Description Document Type Size
1 form3-01092017_070102.html 3  
1 form3-01092017_070102.xml 3 4439
  Complete submission text file 0001415889-17-000048.txt   5873
Mailing Address 9171 TOWNE CENTRE DRIVE, SUITE 440 SAN DIEGO CA 92122
Business Address 9171 TOWNE CENTRE DRIVE, SUITE 440 SAN DIEGO CA 92122 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001411879 (see all company filings)

IRS No.: 900814124 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO CA 92121
Business Address
Berholtz Randy (Reporting) CIK: 0001520374 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52991 | Film No.: 17515758